Página 2 - Melhores Glioma médicos - TOP-67 médicos

A Dra. Viola Fox chefia a Clínica de Hematologia, Oncologia e Cuidados Paliativos do BKZ Solingen, com mais de 15 anos de experiência especializada no tratamento de gliomas e outros tumores.

• Especializar-se em quimioterapia, imunoterapia e terapias direcionadas
• Qualificar-se em genética para aprimorar abordagens de tratamento personalizado
• Atuar na pesquisa em biologia molecular para terapias oncológicas inovadoras
• Ser membro de sociedades de oncologia alemãs e americanas

A Prof. Elke Jaeger realizou mais de 1.100 tratamentos de glioma e está entre os melhores oncologistas da Alemanha há mais de 20 anos.

• 38 anos de especialização em oncologia e hematologia
• Chefe de Oncologia na Clínica Nordwest
• Reconhecida como especialista de destaque em sarcomas
• Listada no ranking dos melhores oncologistas da revista Focus

O Dr. Alemdar é especialista em Oncologia Médica com formação extensiva na Universidade Akdeniz – líder em cuidados oncológicos.

• Certificado em Oncologia Médica desde 2018
• Mais de 15 anos de experiência em oncologia
• Trabalhar no Complexo Hospitalar Medical Park Antalya

O Professor Shlomi Constantini é especialista em cirurgia de glioma e é um membro premiado da American Association of Neurological Surgeons.

• Realizar procedimentos microcirúrgicos e neuroendoscópicos avançados
• Realizar formação em cirurgia de tumores supratentoriais e infratentoriais na Europa
• Deter prémios de investigação por estudos de pressão cerebral e investigação clínica
• Ser membro da Sociedade Europeia de Neurocirurgia Pediátrica e da Federação Internacional de Neuroendoscopia
• Tratar tumores cerebrais em adultos e crianças no Sourasky Medical Center

Neurocirurgião de renome mundial, o Prof. Zvi Ram lidera a Associação Europeia de Sociedades de Neurocirurgia e oferece cuidados inovadores para gliomas no Sourasky Medical Center.

• Especialista em cirurgia complexa de tumores cerebrais com mapeamento cerebral e estimulação cerebral profunda
• Altamente qualificado em técnicas microcirúrgicas e guiadas por imagem para tumores cerebrais
• Conduz pesquisas de ponta em terapias genéticas para câncer cerebral
• Reconhecido com o Goldhirsh Foundation Award por tratamentos neurológicos inovadores

O Dr. Yildiz possui mais de uma década de experiência especializada em oncologia, com foco em casos avançados de cancro no Hospital Universitário Medipol Mega.

• Mais de 15 anos de experiência em oncologia médica
• Deter uma cátedra em oncologia – um especialista que forma outros médicos
• Publicar extensivamente em revistas médicas internacionais sobre vários tipos de cancro
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Interesse especial em tumores neuroendócrinos e gestão de casos complexos

O Prof. Dr. Wolfgang Köstler é um especialista de renome no tratamento de gliomas, especializado em terapias-alvo e medicina oncológica personalizada na Wiener Privatklinik.

• Mais de 20 anos de experiência em oncologia médica
• Foco no desenvolvimento de biomarcadores e biologia tumoral
• Subchefe da Divisão Clínica de Oncologia da Universidade Médica de Viena
• Autor de publicações extensas em importantes periódicos internacionais

Especialista em viroterapia – um dos campos mais recentes da imunologia – com mais de 30 anos de experiência na Clínica Pallas.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduado pelo Instituto Médico de Riga
• Internato em Medicina Interna

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

O Prof. Adjunto Nail Paksoy é um oncologista médico especializado no tratamento de gliomas no Hospital Medipol Bahçelievler, com certificação pela ESMO e vasta experiência em investigação.

• Formação especializada no Instituto de Oncologia da Universidade de Istambul
• Participação em 8 ensaios clínicos internacionais para tratamentos de cancro
• Publicação de múltiplos estudos sobre tumores cerebrais e neuro-oncologia
• Certificado pela ESMO em Oncologia Médica

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Pioneiro na definição de critérios rigorosos para as síndromes neurológicas paraneoplásicas – o Dr. Graus é uma figura proeminente em neuro-oncologia no Hospital Quiron Barcelona.

• Antigo Chefe de Neurologia no Hospital Clinic, Barcelona
• Fundador e ex-presidente da Associação Europeia de Neuro-Oncologia
• Formado em neuro-oncologia no Memorial Sloan-Kettering Cancer Center
• Homenageado com o título de Doutor Honoris Causa pela Universidade de Lyon